Wells Fargo & Company Repligen Corp Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Repligen Corp stock. As of the latest transaction made, Wells Fargo & Company holds 7,801 shares of RGEN stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,801
Previous 8,319 6.23%
Holding current value
$1.14 Million
Previous $1.05 Million 10.69%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$119.79 - $167.35 $62,051 - $86,687
-518 Reduced 6.23%
7,801 $1.16 Million
Q2 2024

Aug 13, 2024
SELL
$120.0 - $182.95 $104,400 - $159,166
-870 Reduced 9.47%
8,319 $1.05 Million
Q1 2024

May 10, 2024
SELL
$170.78 - $208.42 $946,975 - $1.16 Million
-5,545 Reduced 37.63%
9,189 $1.69 Million
Q4 2023

Feb 09, 2024
SELL
$114.17 - $185.35 $2.01 Million - $3.26 Million
-17,573 Reduced 54.39%
14,734 $2.65 Million
Q3 2023

Nov 13, 2023
BUY
$138.78 - $176.51 $224,129 - $285,063
1,615 Added 5.26%
32,307 $5.14 Million
Q2 2023

Aug 15, 2023
SELL
$138.42 - $180.31 $504,817 - $657,590
-3,647 Reduced 10.62%
30,692 $4.34 Million
Q1 2023

May 12, 2023
SELL
$154.26 - $198.1 $66,177 - $84,984
-429 Reduced 1.23%
34,339 $5.78 Million
Q4 2022

Feb 13, 2023
BUY
$162.42 - $220.56 $477,677 - $648,666
2,941 Added 9.24%
34,768 $5.89 Million
Q3 2022

Nov 14, 2022
SELL
$160.42 - $256.21 $1.68 Million - $2.68 Million
-10,476 Reduced 24.76%
31,827 $5.96 Million
Q2 2022

Aug 12, 2022
SELL
$140.68 - $188.02 $2.71 Million - $3.62 Million
-19,244 Reduced 31.27%
42,303 $6.87 Million
Q1 2022

May 16, 2022
BUY
$161.19 - $257.96 $2.16 Million - $3.46 Million
13,409 Added 27.86%
61,547 $11.6 Million
Q4 2021

Feb 14, 2022
SELL
$247.59 - $304.47 $209 Million - $257 Million
-843,182 Reduced 94.6%
48,138 $12.7 Million
Q3 2021

Nov 15, 2021
SELL
$194.77 - $324.21 $16.7 Million - $27.8 Million
-85,652 Reduced 8.77%
891,320 $258 Million
Q2 2021

Aug 16, 2021
BUY
$165.87 - $220.95 $12 Million - $16 Million
72,192 Added 7.98%
976,972 $195 Million
Q1 2021

May 13, 2021
BUY
$180.37 - $226.26 $2.02 Million - $2.54 Million
11,209 Added 1.25%
904,780 $176 Million
Q4 2020

Feb 09, 2021
BUY
$148.08 - $206.57 $10.6 Million - $14.8 Million
71,681 Added 8.72%
893,571 $171 Million
Q3 2020

Nov 05, 2020
BUY
$122.51 - $158.27 $9.76 Million - $12.6 Million
79,706 Added 10.74%
821,890 $121 Million
Q2 2020

Aug 13, 2020
SELL
$94.33 - $140.48 $1.09 Million - $1.62 Million
-11,509 Reduced 1.53%
742,184 $91.7 Million
Q1 2020

May 14, 2020
BUY
$84.96 - $109.14 $64 Million - $82.3 Million
753,693 New
753,693 $72.8 Million

Others Institutions Holding RGEN

# of Institutions
489
Shares Held
54.3M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.14B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email